7DZ-81860-82561
5 vaccinations
6 coded responses
49 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 988 / WA
- Registered
- 2021-02-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Registered in v-safe
-
2021-02-08
Dose 1 — Moderna
- 2021-02-08
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
-
2021-02-22
Survey response — day 14, dose 1MedDRA: Immunisation reaction, Injection site erythema, Injection site induration, Injection site rash, Injection site swelling — Feeling: GoodFree text: Covid arm 9 days after 1st dose. Red, raised, hard rash in upper arm below injection site. Gradually subsiding.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
-
2021-03-08
Dose 2 — Moderna
-
2021-03-08
Survey response — day 0, dose 2MedDRA: Injection site rash — Feeling: Good · Site: PainFree text: Had bad rash on arm below injection site 1 week after 1st dose. Gradually went away.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-06
-
2021-10-24
Dose 3 — Moderna
-
2021-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
- 2022-01-23
-
2022-03-31
Dose 4 — Moderna
- 2022-04-14
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-06-30
-
2022-09-06
Dose 5 — ModernaCo-administered: Flu
- 2022-09-29
-
2022-09-29
Survey response — 6 months, dose 4MedDRA: Nasopharyngitis, SARS-CoV-2 test positive — Feeling: GoodFree text: Covid positive on home test 7/14/22 mild head cold 4 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — day 35, dose 5MedDRA: Fatigue, Headache, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, headache, exhaustion from European trip/jet lag. Home Covid test negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Survey response — day 42, dose 5MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infection. Covid test negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Report sent to call center — day 42, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-06
Survey response — 3 months, dose 5MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had RSV for 3-1/2 weeks in October.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-06
Report sent to call center — 3 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-07
Call successfulNot applicable - Accidental Reporting
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Moderna | |
| 2 | 2021-03-08 | Moderna | |
| 3 | 2021-10-24 | Moderna | No |
| 4 | 2022-03-31 | Moderna | No |
| 5 | 2022-09-06 | Moderna | Flu |
Call center
2 call center cases
2 successful
Free text
Release 4 — day 14, dose 1
Symptoms: Covid arm 9 days after 1st dose. Red, raised, hard rash in upper arm below injection site. Gradually subsiding.
Release 5 — day 0, dose 2
Systemic reaction (other): Had bad rash on arm below injection site 1 week after 1st dose. Gradually went away.
Release 12 — 6 months, dose 4
Symptoms: Covid positive on home test 7/14/22 mild head cold 4 days
Release 12 — day 35, dose 5
Symptoms: Sore throat, headache, exhaustion from European trip/jet lag. Home Covid test negative.
Release 12 — day 42, dose 5
Symptoms: Upper respiratory infection. Covid test negative.
Release 12 — 3 months, dose 5
Symptoms: Had RSV for 3-1/2 weeks in October.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Immunisation reaction | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release